Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer (PROTECT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02359968
Recruitment Status : Active, not recruiting
First Posted : February 10, 2015
Last Update Posted : October 27, 2021
National Cancer Institute, France
Information provided by (Responsible Party):
Centre Oscar Lambret